BlackRock, Inc. 13D and 13G filings for AnaptysBio, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Sale |
2025-03-31 | 13G | AnaptysBio, Inc. ANAB |
BlackRock Inc. BLK |
1,900,844 6.200% |
-647,624 (-25.41%) |
Filing |
| 2025-02-05 1:23 pm Purchase |
2024-12-31 | 13G | AnaptysBio, Inc. ANAB |
BlackRock Inc. BLK |
2,548,468 8.400% |
748,645 (+41.60%) |
Filing |
| 2024-01-26 5:25 pm Sale |
2023-12-31 | 13G | AnaptysBio, Inc. ANAB |
BlackRock Inc. BLK |
1,799,823 6.800% |
-56,443 (-3.04%) |
Filing |
| 2023-01-31 5:52 pm Sale |
2022-12-31 | 13G | AnaptysBio, Inc. ANAB |
BlackRock Inc. BLK |
1,856,266 6.500% |
-9,022 (-0.48%) |
Filing |
| 2022-02-02 7:11 pm Sale |
2021-12-31 | 13G | AnaptysBio, Inc. ANAB |
BlackRock Inc. BLK |
1,865,288 6.800% |
-42,546 (-2.23%) |
Filing |
| 2021-01-28 5:56 pm Sale |
2020-12-31 | 13G | AnaptysBio, Inc. ANAB |
BlackRock Inc. BLK |
1,907,834 7.000% |
-140,780 (-6.87%) |
Filing |